rVSV-ZEBOV has very promising results on a trial performed in 2015 with very promising results. The<unk> is not approved yet however it can be used during any epidemic occurring before approval after giving informed consent. INO-4212 is another promising<unk> under experimentation with the results of ongoing trials expected to be released by May 2018.
Ebola vaccines
Malaria vaccine
Polio vaccine
MMR vaccine
HIV vaccine
Cholera vaccine
Caries vaccine
Smallpox vaccine